Copyright: ©Author(s) 2026.
World J Gastroenterol. Jun 28, 2026; 32(24): 118757
Published online Jun 28, 2026. doi: 10.3748/wjg.118757
Published online Jun 28, 2026. doi: 10.3748/wjg.118757
Table 5 Adverse events of grade 3 or 4 in the sarcopenic and non-sarcopenic patients, n (%)
| Variable | Sarcopenic patients (n = 46) | Non-sarcopenic patients (n = 104) | P value |
| Total adverse events | 22 (47.8) | 28 (26.9) | 0.015 |
| Hematologic toxicity | 16 (34.8) | 15 (14.4) | 0.001 |
| Neutropenia | 15 (32.6) | 15 (14.4) | |
| Anemia | 1 (2.2) | 0 (0.0) | |
| Thrombocytopenia | 1 (2.2) | 0 (0.0) | |
| Non-hematologic toxicity | 11 (23.9) | 13 (12.5) | 0.093 |
| Nausea | 0 (0.0) | 1 (1.0) | |
| Loss of appetite | 2 (4.3) | 1 (1.0) | |
| Fatigue | 3 (6.5) | 0 (0.0) | |
| Diarrhea | 0 (0.0) | 1 (1.0) | |
| Skin rash | 5 (10.9) | 3 (2.9) | |
| Peripheral neuropathy | 2 (4.3) | 8 (7.7) | |
| Interstitial pneumonia | 3 (6.5) | 1 (1.0) |
- Citation: Akazawa Y, Ohtani M, Murata Y, Tanaka T, Nosaka T, Takahashi K, Naito T, Nakamoto Y. Three-dimensional psoas muscle volume and longitudinal changes as predictors of outcomes in older patients with advanced pancreatic cancer. World J Gastroenterol 2026; 32(24): 118757
- URL: https://www.wjgnet.com/1007-9327/full/v32/i24/118757.htm
- DOI: https://dx.doi.org/10.3748/wjg.118757